• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与特发性慢性肾病猫相比,皮下输尿管旁路置入术后猫慢性肾病的进展情况。

Progression of Chronic Kidney Disease in Cats After Subcutaneous Ureteral Bypass Placement Compared to Cats With Idiopathic Chronic Kidney Disease.

作者信息

Bennett Zoe, Lawson Jack S, Chang Yu-Mei, Shelton Edward, Elliott Jonathan, Syme Harriet M, Geddes Rebecca F

机构信息

Clinical Science and Services, Royal Veterinary College, Hatfield, UK.

Comparative Biomedical Sciences, Royal Veterinary College, London, UK.

出版信息

J Vet Intern Med. 2025 Sep-Oct;39(5):e70242. doi: 10.1111/jvim.70242.

DOI:10.1111/jvim.70242
PMID:40947676
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12434176/
Abstract

BACKGROUND

Chronic kidney disease (CKD) is a common sequela of ureteral obstruction, but many cats are non-azotemic after subcutaneous ureteral bypass (SUB) placement.

OBJECTIVES

Compare CKD progression rates after SUB placement with idiopathic CKD (iCKD), and explore variables associated with progression.

ANIMALS

Seventy-one referred cats after SUB placement for ureteral obstruction and 89 primary care cats with iCKD.

METHODS

Retrospective observational longitudinal study. Baseline (3-6 months after SUB or at CKD diagnosis for iCKD cases) clinicopathological data and CKD progression (≥ 25% increase in creatinine concentration [Cr]) rates were compared between iCKD and SUB cats. Univariable logistic regression identified variables associated with SUB cat CKD progression.

RESULTS

Baseline Cr was lower in the SUB group (SUB, 2.0 mg/dL; iCKD, 2.3 mg/dL; p = 0.01). For SUB cats with a ≥ 25% increase in Cr within 1 year, 45% (9/20) had SUB obstruction. Of the remaining 11 cats, 35% had a positive urine culture. Only SUB blockage was associated with CKD progression in SUB cats (odds ratio, 33.33; confidence interval [CI], 3.80-292.60; p = 0.002). Progression of CKD within 1 year did not differ between groups (iCKD, 29.5%; SUB, 28.1%; p = 0.85), even after exclusion of obstructed cases (iCKD, 29.5%; SUB, 17.7%; p = 0.12). Median time to CKD progression was not different between groups (iCKD, 833 days; range, 21-2141; SUB, 653 days; range, 43-1662; p = 0.80).

CONCLUSIONS AND CLINICAL IMPORTANCE

Progression of CKD after SUB placement occurs with similar frequency and time frame as in cats with iCKD, but should prompt assessment for SUB blockage and pyelonephritis.

摘要

背景

慢性肾脏病(CKD)是输尿管梗阻的常见后遗症,但许多猫在接受皮下输尿管旁路(SUB)手术后并无氮质血症。

目的

比较SUB手术后CKD的进展率与特发性CKD(iCKD),并探索与进展相关的变量。

动物

71只因输尿管梗阻接受SUB手术的转诊猫和89只患有iCKD的初级保健猫。

方法

回顾性观察纵向研究。比较iCKD猫和SUB猫的基线(SUB术后3 - 6个月或iCKD病例CKD诊断时)临床病理数据及CKD进展(肌酐浓度[Cr]增加≥25%)率。单变量逻辑回归确定与SUB猫CKD进展相关的变量。

结果

SUB组的基线Cr较低(SUB组为2.0mg/dL;iCKD组为2.3mg/dL;p = 0.01)。对于1年内Cr增加≥25%的SUB猫,45%(9/20)存在SUB梗阻。其余11只猫中,35%尿培养呈阳性。在SUB猫中,只有SUB堵塞与CKD进展相关(比值比,33.33;置信区间[CI],3.80 - 292.60;p = 0.002)。两组1年内CKD进展情况无差异(iCKD组为29.5%;SUB组为28.1%;p = 0.85),即使排除梗阻病例后也是如此(iCKD组为29.5%;SUB组为17.7%;p = 0.12)。两组CKD进展的中位时间无差异(iCKD组为833天;范围,21 - 2141天;SUB组为653天;范围,43 - 1662天;p = 0.80)。

结论及临床意义

SUB术后CKD的进展频率和时间框架与iCKD猫相似,但应促使对SUB堵塞和肾盂肾炎进行评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ec/12434176/8bc67df4516d/JVIM-39-e70242-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ec/12434176/8bc67df4516d/JVIM-39-e70242-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ec/12434176/8bc67df4516d/JVIM-39-e70242-g001.jpg

相似文献

1
Progression of Chronic Kidney Disease in Cats After Subcutaneous Ureteral Bypass Placement Compared to Cats With Idiopathic Chronic Kidney Disease.与特发性慢性肾病猫相比,皮下输尿管旁路置入术后猫慢性肾病的进展情况。
J Vet Intern Med. 2025 Sep-Oct;39(5):e70242. doi: 10.1111/jvim.70242.
2
Evaluation of serum insulin-like growth factor 1 concentrations in non-diabetic cats with chronic kidney disease.慢性肾病非糖尿病猫血清胰岛素样生长因子1浓度的评估。
Domest Anim Endocrinol. 2025 Apr;91:106898. doi: 10.1016/j.domaniend.2024.106898. Epub 2024 Nov 28.
3
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
4
Metabolic Alterations Associated With Rapidly Progressive Chronic Kidney Disease in Cats.猫快速进展性慢性肾病相关的代谢改变
J Vet Intern Med. 2025 Jul-Aug;39(4):e70170. doi: 10.1111/jvim.70170.
5
Pathological alteration and caspase-dependent activity of feline kidneys in natural infection of feline morbillivirus.猫瘟病毒自然感染时猫肾脏的病理改变及半胱天冬酶依赖性活性
BMC Vet Res. 2025 Jul 25;21(1):489. doi: 10.1186/s12917-025-04953-z.
6
The Impact of Primary Renal Diagnosis on Prognosis and the Varying Predictive Power of Albuminuria in the NURTuRE-CKD Study.NURTuRE-CKD研究中,原发性肾脏诊断对预后的影响及蛋白尿的不同预测能力。
Am J Nephrol. 2025;56(1):1-12. doi: 10.1159/000541770. Epub 2024 Oct 4.
7
Oral adsorbents for preventing or delaying the progression of chronic kidney disease.用于预防或延缓慢性肾脏病进展的口服吸附剂。
Cochrane Database Syst Rev. 2014 Oct 15;2014(10):CD007861. doi: 10.1002/14651858.CD007861.pub2.
8
Assessment of alendronate and dietary treatment in the management of feline idiopathic ionised hypercalcaemia and ionised hypercalcaemia associated with chronic kidney disease: 29 cases (2016-2022).评估阿仑膦酸钠和饮食治疗在猫特发性离子性高钙血症和与慢性肾脏病相关的离子性高钙血症管理中的作用:29 例病例(2016-2022 年)。
J Small Anim Pract. 2024 Sep;65(9):682-693. doi: 10.1111/jsap.13755. Epub 2024 Jul 4.
9
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在患有早期(1 至 3 期)非糖尿病慢性肾脏病的成人中的应用。
Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3.
10
Subcutaneous ureteral bypass device placement with intraoperative ultrasound guidance, with or without microsurgical ureterotomy, in 24 cats.24 只猫中行术中超声引导下皮下输尿管旁路装置放置术,联合或不联合显微外科输尿管切开术。
J Feline Med Surg. 2021 Dec;23(12):1183-1191. doi: 10.1177/1098612X211002014. Epub 2021 Mar 23.

本文引用的文献

1
Long-Term Outcomes After Prophylactic Infusion of 2% Tetrasodium Ethylenediaminetetraacetic Acid in 95 Subcutaneous Ureteral Bypass Devices in 66 Cats With Benign Ureteral Obstructions.66只患有良性输尿管梗阻的猫的95个皮下输尿管旁路装置预防性输注2%乙二胺四乙酸四钠后的长期结果
J Vet Intern Med. 2025 Mar-Apr;39(2):e70006. doi: 10.1111/jvim.70006.
2
Analysis of lower urinary tract signs and bacteriuria in cats with subcutaneous ureteral bypass systems.皮下输尿管旁路系统治疗猫下尿路症状及菌尿症的分析
Vet Rec Open. 2023 Aug 1;10(2):e69. doi: 10.1002/vro2.69. eCollection 2023 Dec.
3
Risk factors for upper urinary tract uroliths and ureteral obstruction in cats under referral veterinary care in the United Kingdom.
英国转诊兽医护理下猫上尿路结石和输尿管梗阻的危险因素。
J Vet Intern Med. 2023 Mar;37(2):567-577. doi: 10.1111/jvim.16659. Epub 2023 Mar 1.
4
Frequency of histologic lesions in the kidneys of cats without kidney disease.无肾病猫肾脏组织病变的频率。
J Feline Med Surg. 2022 Dec;24(12):e472-e480. doi: 10.1177/1098612X221123768.
5
Use of tetrasodium EDTA acid for the treatment of intraluminal obstruction of subcutaneous ureteral bypass devices.使用四钠 EDTA 酸治疗皮下输尿管旁路装置腔内阻塞。
J Feline Med Surg. 2022 Oct;24(10):e330-e337. doi: 10.1177/1098612X221107795. Epub 2022 Jun 28.
6
Upper urolithiasis in cats with chronic kidney disease: prevalence and investigation of serum and urinary calcium concentrations.猫慢性肾病伴上尿路结石:血清和尿钙浓度的患病率及研究。
J Feline Med Surg. 2022 Jun;24(6):e70-e75. doi: 10.1177/1098612X221089856. Epub 2022 Apr 26.
7
Renal biomarkers in cats: A review of the current status in chronic kidney disease.猫的肾脏生物标志物:慢性肾脏病现状综述。
J Vet Intern Med. 2022 Mar;36(2):379-396. doi: 10.1111/jvim.16377. Epub 2022 Feb 26.
8
Subcutaneous ureteral bypass device placement in 81 cats with benign ureteral obstruction (2013-2018).81 例良性输尿管梗阻猫行皮下输尿管旁路装置放置术(2013-2018 年)。
J Vet Intern Med. 2021 Nov;35(6):2778-2786. doi: 10.1111/jvim.16280. Epub 2021 Dec 10.
9
Complications and survival after subcutaneous ureteral bypass device placement in 24 cats: a retrospective study (2016-2019).24 例猫皮下输尿管旁路装置放置术后并发症及生存情况的回顾性研究(2016-2019 年)。
J Feline Med Surg. 2021 Aug;23(8):759-769. doi: 10.1177/1098612X20975374. Epub 2020 Nov 24.
10
Survival and complications in cats treated with subcutaneous ureteral bypass.皮下输尿管旁路术治疗猫的生存和并发症。
J Small Anim Pract. 2021 Jan;62(1):4-11. doi: 10.1111/jsap.13226. Epub 2020 Sep 14.